StockPriceToday
Canopy Growth Corporation (CGC)
About Canopy Growth Corporation
Canopy Growth Corporation (CGC) was founded in 2013 by Bruce Linton and Chuck Rifici as Tweed Inc., becoming one of the first licensed cannabis producers in Canada under the country's medical marijuana regulations. The company went public in 2014 and has since evolved into one of the largest cannabis companies globally through organic growth and strategic acquisitions. CGC stock price reflects the company's pioneering position in the legal cannabis industry and its comprehensive brand portfolio spanning medical and adult-use cannabis markets.
The company's leadership has undergone significant changes as the cannabis industry has evolved. Founder Bruce Linton served as CEO until 2019, leading the company's rapid expansion and international growth strategy. Current leadership, including CEO David Klein who joined from Constellation Brands, has focused on operational efficiency, cost management, and sustainable growth strategies. The company has attracted significant investment from Constellation Brands, which maintains a substantial equity position. The CGC stock price has been influenced by regulatory developments and market dynamics in the evolving cannabis sector.
Canopy Growth operates across multiple cannabis market segments, including medical cannabis, adult-use recreational products, and hemp-derived CBD products. The company's brand portfolio includes Tweed, Tokyo Smoke, Doja, and Martha Stewart CBD, serving diverse consumer preferences and market segments. With operations in Canada, the United States, and other international markets, Canopy Growth has built cultivation, manufacturing, and distribution capabilities to serve various legal cannabis markets. Investors tracking CGC stock price should monitor cannabis legalization trends, regulatory changes affecting market access, competitive dynamics in legal cannabis markets, and the company's progress toward profitability as the industry continues to mature and consolidate.
CGC Stock 12 Month Chart
Latest News for CGC
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.
Latest cannabis stocks market update for combining the close, rate moves, earnings reactions, filings and company-specific operating evidence.
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
Other Popular Stocks
Weibo Corporation (WB) is a leading social media platform in China, often referred to as the Chinese Twitter, enabling users to create, share and...
Blueprint Medicines Corporation is a biotechnology company developing precision therapies for cancer and blood disorders.
Exelixis Inc. (EXEL) is a commercial-stage biotechnology company focused on developing and commercializing innovative cancer therapies, particularly kinase inhibitors for oncology applications.